Skip to main content
Equibles
HCA logo

HCA · HCA Healthcare, Inc.

Track HCA — free

Use HCA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about HCA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$404.68 -7.06 (-1.71%) At close · Aug 14
Market Cap
$89.77B
Shares
221.84M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$404.68 Open$410.46 Day$403.78–412.69 52W close$361.32–545.13 Avg vol 30d1.6M Short int6.1M · 2.7% float · 3.5d Short vol54% Last earningsJul 24, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 23, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 28, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Strong Quant / Vol Moderate
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −11%
      below
      Price vs 50-day avg +3%
      above
      RSI (14) 52
      neutral
      MACD trend Positive
      52-week position 24%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +9%
      trailing
      6-month return −25%
      trailing
      YTD return −13%
      this year
      Relative strength −38%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $392 › 200d $456 — 200d above 50d
      Institutional flow Distributing
      -8% holders QoQ · +120 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      2.73% of float · ▲ +4.0% MoM · 3.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      1,313 holders — mid 3-yr range
      Squeeze score 50
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +7%
      Y/Y
      EPS growth +29%
      Y/Y
      Free cash flow $7.7B
      Valuation P/E 13.9
      below peers
      Buyback $7.2B
      remaining
      Balance sheet $45.5B
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 30%
      annualized · 1-yr
      Max drawdown −34%
      past year
      ATR 3.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 2 of last 2
      Latest guidance · from the 8-K filed Jul 24, 2026
      Revenues · 2026 $77B – $79.5B
      Adjusted EBITDA · 2026 Non-GAAP $15.4B – $16.1B
      Net Income Attributable to HCA Healthcare, Inc. · 2026 $6.3B – $6.7B
      EPS (diluted) · 2026 $28.70 – $30.50
      Medicaid Supplemental Payment Programs · 2026 $300M – $500M
      Prior guidance period ended · from the Earnings Call filed Sep 30, 2025
      Revenues · full year $75B – $76.5B
      Net income attributable to HCA Healthcare · full year $6.5B – $6.72B
      Adjusted EBITDA · full year $15.25B – $15.65B
      Diluted earnings per share · full year $27.00 – $28.00
      Supplemental payment full-year net benefit (2025 vs 2024) · full year $250M – $350M
      Capital spending · full year $5B
      Guided vs delivered · last 2 settled
      Revenues full year 2024
      guided $67.75B – $70.25B
      $70.6B Beat +2.3%
      Diluted earnings per share full year 2024
      guided $19.70 – $21.20
      $22.00 Beat +7.6%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −11% Bearish
      Price vs 50-day avg
      +3% Bullish
      RSI (14)
      52 Neutral
      MACD trend
      Positive Bullish
      52-week position
      24% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $392 › 200d $456 — 200d above 50d
      Institutional flow Distributing
      -8% holders QoQ · +120 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      2.73% of float · ▲ +4.0% MoM · 3.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      1,313 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $361 Now $405 · 24% Range high $545
      vs 200-day avg -11% vs 50-day avg +3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      ambulatory sites of care 2,600 first quarter 2026 —
      hospitals operated 189 first quarter 2026 —
      Adjusted EBITDA margin non-GAAP 20.6% Year Ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HCA
      HCA Healthcare, Inc.
      this stock
      		$89.77B -13.3% +7.1% 13.9 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      		 $30.87B -4.4% — — 0.0%
      THC
      Tenet Healthcare Corp
      		 $21.57B +34.8% +0.9% 10.3 4.0%
      FMS
      Fresenius Medical Care AG
      		 $12.65B -0.2% +5.9% — 0.5%
      EHC
      Encompass Health Corp
      		 $12.19B +16.4% +10.5% 20.1 3.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      1,313
      % held
      59.8%
      Net QoQ
      -513.3K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      936
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      6.1M
      Days to cover
      3.5d
      Change
      +232.2K sh
      View
      Short Volume
      Short vol %
      54%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      6
      Value
      $2.3K
      As of
      Jul 1, 2026
      View
      Off-Exchange
      Off-exchange %
      44.1%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Buy
      Member
      Jared Moskowitz
      Amount
      $1.0K–$15.0K
      Traded
      Jun 17, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $75.6B
      Net income (FY)
      $6.8B
      EPS diluted
      $28.33
      View
      Buybacks
      Authorized
      $10.0B
      Remaining
      $7.2B
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 29, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $903.5K
      Shares
      1.7K
      Filed
      Feb 18, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 24, 2026
      View
      Investor Relations
      Latest news
      HCA Healthcare Reports Second Qua…
      Published
      Jul 24, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      HCA -2.1% +9.0% -24.5% +0.5% -13.3%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -2.5% +4.6% -38.3% -3.4% -27.2%

      Capital returns

      Latest dividend
      $0.78 / share · ex Jun 16, 2026
      Declared · upcoming
      $0.78 / share · ex Sep 16, 2026
      Raised 8.3%
      Paid (TTM)
      $3.00 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.74%
      Buyback program · as of Jun 30, 2026
      Authorized
      $10.00B
      Spent (derived)
      $2.79B
      Remaining
      $7.21B
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 860730 CUSIP 40412C101 13F (30d) 1195 filings 1159 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)